Literature DB >> 9508429

Development of pneumocystosis animal models: corticosteroid-treated Wistar rat; SCID mouse and nude rat.

E M Aliouat1, A Martinez, E Jimenez, E Dei-Cas, C Mullet, P Delcourt, D Gargallo-Viola.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9508429     DOI： 10.1111/j.1550-7408.1997.tb05765.x

Source DB:  PubMed          Journal:  J Eukaryot Microbiol        ISSN： 1066-5234            Impact factor:   3.346


× No keyword cloud information.
  8 in total

Review 1.  Genetics of surface antigen expression in Pneumocystis carinii.

Authors:  J R Stringer; S P Keely
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

2.  In vitro pharmacodynamic parameters of sordarin derivatives in comparison with those of marketed compounds against Pneumocystis carinii isolated from rats.

Authors:  P Aviles; E M Aliouat; A Martinez; E Dei-Cas; E Herreros; L Dujardin; D Gargallo-Viola
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

3.  Activities of sordarins in experimental models of candidiasis, aspergillosis, and pneumocystosis.

Authors:  A Martinez; P Aviles; E Jimenez; J Caballero; D Gargallo-Viola
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

4.  Development of Cryptosporidium parvum-induced gastrointestinal neoplasia in severe combined immunodeficiency (SCID) mice: severity of lesions is correlated with infection intensity.

Authors:  Gabriela Certad; Colette Creusy; Tramy Ngouanesavanh; Karine Guyot; Nausicaa Gantois; Anthony Mouray; Thierry Chassat; Nicolas Flament; Laurence Fleurisse; Anthony Pinon; Laurence Delhaes; Eduardo Dei-Cas
Journal:  Am J Trop Med Hyg       Date:  2010-02       Impact factor: 2.345

5.  Therapeutic efficacies of GW471552 and GW471558, two new azasordarin derivatives, against pneumocystosis in two immunosuppressed-rat models.

Authors:  Elena Jimenez; Antonio Martínez; El Moukhtar Aliouat; Jesus Caballero; Eduardo Dei-Cas; Domingo Gargallo-Viola
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

6.  New rat model of Pneumocystis pneumonia induced by anti-CD4(+) T-lymphocyte antibodies.

Authors:  Timothy D Thullen; Alan D Ashbaugh; Kieran R Daly; Michael J Linke; Paul E Steele; Peter D Walzer
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

7.  In vitro and in vivo activity of iclaprim, a diaminopyrimidine compound and potential therapeutic alternative against Pneumocystis pneumonia.

Authors:  E M Aliouat; E Dei-Cas; N Gantois; M Pottier; C Pinçon; S Hawser; A Lier; D B Huang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-01-12       Impact factor: 3.267

8.  Cryptosporidium parvum infection in SCID mice infected with only one oocyst: qPCR assessment of parasite replication in tissues and development of digestive cancer.

Authors:  Sadia Benamrouz; Karine Guyot; Sophie Gazzola; Anthony Mouray; Thierry Chassat; Baptiste Delaire; Magali Chabé; Pierre Gosset; Eric Viscogliosi; Eduardo Dei-Cas; Colette Creusy; Valerie Conseil; Gabriela Certad
Journal:  PLoS One       Date:  2012-12-13       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.